Literature DB >> 10840296

Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole.

H Schulz1, S Miehlke, D Antos, K U Schentke, M Vieth, M Stolte, E Bayerdörffer.   

Abstract

BACKGROUND: Barrett's esophagus is a premalignant condition induced by gastroesophageal reflux. The aim of this prospective study was to assess the efficacy of argon plasma coagulation in combination with high-dose omeprazole therapy to ablate nondysplastic Barrett's epithelium.
METHODS: In 73 patients with histologically confirmed Barrett's epithelium, argon plasma coagulation was used in combination with maximal acid suppression (omeprazole 40 mg three times a day). Histologic and endoscopic changes were evaluated at 6- and 12-month intervals.
RESULTS: In 69 of 70 patients (98.6%) complete squamous regeneration was achieved after a median of 2 argon plasma coagulation sessions (range 1 to 5). During a median follow-up of 12 months (range 2 to 51 months) there has been no relapse or evidence of the development of dysplasia under continuous acid suppression. Three patients (4.3%) developed a mild stricture of the distal esophagus that resolved after a single session of bougie dilation.
CONCLUSIONS: In our experience, argon plasma coagulation in combination with high-dose omeprazole treatment is an effective and safe technique for complete ablation of nondysplastic Barrett's epithelium. Restoration of squamous mucosa after argon plasma coagulation appears to be long-lasting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10840296

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  34 in total

1.  [Barrett esophagus: ablative methods of treatment].

Authors:  M Jung; C Ell
Journal:  Internist (Berl)       Date:  2003-01       Impact factor: 0.743

2.  [Laparoscopic fundoplication. Indications and results].

Authors:  K H Fuchs; H Feussner
Journal:  Internist (Berl)       Date:  2003-01       Impact factor: 0.743

3.  Argon plasma coagulation therapy for ablation of Barrett's oesophagus.

Authors:  J Deviere
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

4.  Sixteen-year follow-up of Barrett's esophagus, endoscopically treated with argon plasma coagulation.

Authors:  Mariana Milashka; Annabelle Calomme; Jean Luc Van Laethem; Daniel Blero; Pierre Eisendrath; Olivier Le Moine; Jacques Devière
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

Review 5.  Current status of ablative therapies in esophageal disorders.

Authors:  P Sharma
Journal:  Curr Gastroenterol Rep       Date:  2001-06

Review 6.  Barrett's esophagus with high-grade dysplasia: focus on current treatment options.

Authors:  Leonidas Lekakos; Nikolaos P Karidis; Dimitrios Dimitroulis; Christos Tsigris; Gregory Kouraklis; Nikolaos Nikiteas
Journal:  World J Gastroenterol       Date:  2011-10-07       Impact factor: 5.742

Review 7.  Prevention of adenocarcinoma by reversing Barrett's esophagus with mucosal ablation.

Authors:  Richard E Sampliner
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

Review 8.  Surveillance in Barrett's oesophagus: a personal view.

Authors:  K K Basu; J S de Caestecker
Journal:  Postgrad Med J       Date:  2002-05       Impact factor: 2.401

9.  Endoscopic therapy of Barrett's: what more do we need to know?

Authors:  J-L Van Laethem; J Devière
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

Review 10.  Endoscopic management of Barrett's esophagus: advances in endoscopic techniques.

Authors:  Ali Azarm; Ismet Lukolic; Meenal Shukla; Ronald Concha-Parra; Frank Gress
Journal:  Dig Dis Sci       Date:  2012-07-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.